Stay updated on GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Sign up to get notified when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.

Latest updates to the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link in the footer. The core study content and status appear unchanged.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe study record versions list now shows Revision: v3.3.2 and removes Revision: v3.3.1, reflecting a small history update.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.3.1 is added to the study record history and v3.2.0 is removed from the list.SummaryDifference0.1%

- Check46 days agoChange DetectedThe notice about government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedVersion 2 updates Study Status, Sponsor/Collaborators, and Contacts/Locations. Version 3 updates Recruitment Status, Study Status, Study Design, and Contacts/Locations.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded a government funding notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates current operating status and references official sources.SummaryDifference13%

Stay in the know with updates to GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.